3Bandin O, Courvalin JC, Poupon R, et al. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology, 1996, 23: 1020-1024.
4Bach N, Odin JA. Primary biliary cirrhosis: a Mount Sinai perspective. Mt Sinai J Med, 2003, 70: 242-250.
5Kamihira T, Shimoda S, Harada K, et al. Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology, 2003, 125: 1379-1387.
6Mitchison HC, Palmer JM, Bassendine MF, et al. A controlled trial of prednisolone treatment in primary biliary cirrhosis: threeyear results. J Hepatol, 1992, 15: 336-344.
7Leuschner M, Guldutuna S, You T, et al. Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J Hepatol,1996, 25: 49-57.
8Chan CW, Papatheodoridis GV, Goulis J, et al. Ursodeoxycholic acid and histological progression in primary biliary cirrhosis. J Hepatol, 2003, 39: 1094-1095.
10Muratori P, Muratori L, Ferrari R, et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol, 2003, 98: 431-437.
二级参考文献12
1Vitali C,Bombardieri S,Moutsopoulos HM,et al. Preliminary criteria for the classification of Sjogren′s syndrome:results of a prospective concerted action supported by the European Commumity. Arthritis Rheum, 1993,36:340-347.
2Vitali C,Bombardieri S,Mortsopoulos HM,et al. Assessment of the European classification criteria for Sjogren′s syndrome in a series of clinically defined eases:results of a prospective multicentre study. Ann Rheum Dis,1996,55:116-121.
3Zhang NZ,Shi CHS,Yao QP,et al.Prevalence of Sjogren′s syndrome in People′s Republic of China. J Rheum, 1995,22:659.
4Takei S,Nonaka Y,Inmanaya H,et al. Revised Japanese criteria for Sjogren′s syndrome is useful in diagnosing childhood-onset patients. Arthritis Rheum,2003,48(Suppl): 1315.
5Vitali C,Bombardieoi S,Jonssin R,et al. Classification criteria for Sjogren′s syndrome:a revised version of European criteria proposed by the American European Consensus Group. Ann Rheum Dis,2002,61:554-558.
6Daniels TE,Silverman S,Michiaski JP,et al. The oral component of Sjogren′s syndrome.Oral Surg, 1975,39:875.
5Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases Practice Guidelines[J]. Hepatology ,2000,31 : 1005-1013.
6Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Disease practice guidelines [J]. Hepatology, 2000, 31:1005 - 1013.
8Longo M, Crosignani A, Battezzati PM, et al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis[J]. Gut, 2002,51:265 -269.
9Washington K. Autoimmune cholangitis: not just AMA-negative primary biliary cirrhosis[ J]. Adv Anat Pathol, 2002,9 ;244- 250.
10Nakajima M, Shimizu H, Miyazaki A, et al. Detection of IgA, IgM,and IgG subclasses of anti M2 antibody by immunoblotting in autoimmune cholangitis: Is autoimmune cholangitis an early stage of primary primary cirrhosis[J] ? J Gastroenterol, 1999,34:607 -612.
